F845-0105 Screening compound: 2-[3-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-N-(3,5-dimethylphenyl)-N-methylthiophene-3-sulfonamide

F845-0105 Screening compound: 2-[3-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-N-(3,5-dimethylphenyl)-N-methylthiophene-3-sulfonamide
F845-0105 Screening compound: 2-[3-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-N-(3,5-dimethylphenyl)-N-methylthiophene-3-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F845-0105
2-[3-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-N-(3,5-dimethylphenyl)-N-methylthiophene-3-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F845-0105

Molecular Formula

C22H19N3O5S2 (C22 H19 N3 O5 S2)

Compound Name

2-[3-(2H-1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-N-(3,5-dimethylphenyl)-N-methylthiophene-3-sulfonamide

IUPAC name

2-[3-(2H-13-benzodioxol-5-yl)-124-oxadiazol-5-yl]-N-(35-dimethylphenyl)-N-methylthiophene-3-sulfonamide

SMILES

Cc1cc(N(C)S(c2c(-c3nc(-c(cc4)cc5c4OCO5)no3)scc2)(=O)=O)cc(C)c1

InChI

InChI=1S/C22H19N3O5S2/c1-13-8-14(2)10-16(9-13)25(3)32(26,27)19-6-7-31-20(19)22-23-21(24-30-22)15-4-5-17-18(11-15)29-12-28-17/h4-11H,12H2,1-3H3

InChI Key

MOHBPDNCJHXYMX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11997734

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

469.54

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.992

Distribution Coefficient, logD

5.992

Water Solubility, LogSw

-5.64

Polar Surface Area

82.599

Acid Dissociation Constant (pKa)

28.80

Base Dissociation Constant (pKb)

-3.21

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

F845-0105 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F845-0105 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F845-0105?
Check Price and Availability of F845-0105, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F845-0105 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F845-0105
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F845-0105
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F845-0105 available by request